circulating tumor cell analysis

OTHER3 trials

Sponsors

UNICANCER, Cancer Trials Ireland, Nanjing Tongren Hospital

Conditions

Breast CancerCirculating Tumor CellMetastatic CancerProstate CancerSquamous Cell Carcinoma of the Head and Neck

Phase 2

Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases

CompletedNCT00967031

UNICANCERBreast Cancer, Metastatic Cancer

Start: 2009-04-30Updated: 2013-01-18

Unknown Phase

Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2

CompletedNCT01160705

Cancer Trials IrelandMetastatic Cancer, Prostate Cancer

Start: 2009-11-30Updated: 2020-11-17

CTC Detection Rate in SCCHN With a in Vivo Device

Nanjing Tongren HospitalCirculating Tumor Cell, Squamous Cell Carcinoma of the Head and Neck

Start: 2016-06-22End: 2017-04-20Target: 50Updated: 2017-03-07

Related Papers

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Journal of Clinical Oncology2020-07-17586 citations

Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial.

2013-09-0644 citations

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study.

2012-11-02534 citations